ArticleNeurology2024

Comparative Effectiveness of Natalizumab, Fingolimod, and Injectable Therapies in Pediatric-Onset Multiple Sclerosis: A Registry-Based Study.

Tim Spelman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.